VistaGen Therapeutics
VTGN
VTGN
21 hedge funds and large institutions have $2.36M invested in VistaGen Therapeutics in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
70% less capital invested
Capital invested by funds: $7.99M → $2.36M (-$5.62M)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$73.5K | |
| 2 | +$31K | |
| 3 | +$27K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11K |
Top Sellers
| 1 | -$1.66M | |
| 2 | -$979K | |
| 3 | -$462K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$203K |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$32K |